Call Us Now

+91 9606900005 / 04

For Enquiry

legacyiasacademy@gmail.com

Twenty-first century solutions to snake bites

Why in news ? Relevance Scale of the problem Basics — venom, species and clinical effects Conventional antivenom — process & limitations Twenty-first-century approach — nanobody / recombinant technology Why this matters for India ?— policy & health relevance Challenges going forward Way ahead — actionable priorities

IDF Diabetes Atlas 2025

Why is it in News? Relevance GS II – Social Justice & Health GS III – Human Capital & Development What is the IDF Diabetes Atlas? Key Global Findings (Data-driven) 1. Scale of the Epidemic  Diabetes growth is structural, not cyclical. 2. Income-Level Distribution 3. Urban–Rural Divide Country-wise Diabetes Load (Top 10 Focus) 2024 Rankings 2050 Projections Why […]

Gallbladder cancer

Why in News? Relevance GS 2 – Governance GS 3 – Environment & Health What is Gallbladder Cancer?  Why is GBC Concentrated in the Gangetic Belt? Gendered Burden: Why Women are Disproportionately Affected Economic & Social Impact Governance Failures at the Core (A) Environmental Governance (B) Health Surveillance Failure Why GBC Remains “Invisible” What Needs to […]

Brain-Stem Death (BSD)

WHY IN NEWS ? Relevance : GS Paper III – Health Sector & Human Resource Development WHAT IS ORGAN TRANSPLANTATION LAW IN INDIA? (A) Deceased Donor Transplant (B) Living Donor Transplant WHAT IS BRAIN-STEM DEATH (BSD)? WHY INDIA’S ORGAN TRANSPLANT PERFORMANCE IS POOR KEY LEGAL CONFUSIONS AROUND BSD Q1. Is BSD legally equivalent to cardiac […]

What is GLP-1 drugs?

Why is it in News? Relevance GS-II: Health GS-III: Science & Tech GS-II: Equity & Public Policy What Are GLP-1 Drugs? Examples of GLP-1 Drugs Why GLP-1 Matters Globally Impact Key Elements of WHO’s New Guidelines Conditional Recommendation Must Accompany Behavioural Interventions Equity as Central Principle Why WHO Issued Guidelines Now ? Concerns Acknowledged by […]

How Antibiotic Misuse Is Fuelling a Crisis in ICUs Across India 

Why is it in News? Relevance GS 2 – Health GS 3 – Science & Technology GS 3 – Disaster Management / Public Health Emergency  What is Antimicrobial Resistance (AMR)?  Scale of the Crisis in ICUs  Why Antibiotic Misuse Is Rising ?  Key Findings From ICMR Data  ICU-Specific Challenges  Consequences of Rising AMR  Structural Issues Fueling the Problem […]

1 doctor per 1000 population

Why it is in news ? Relevance GS2 – Health / Governance GS3 – Economy What is the claimed “WHO ratio”? What does WHO actually prescribe? WHO benchmarks: How did the 1:1,000 myth originate? Government’s use of the ratio (2015–2024) Result: What do global datasets show? Based on WHO’s National Health Workforce Accounts (NHWA): a) Doctors per […]

Indigenous Gene Editing Tool (Birsa-101)

 Why Is It in News? Relevance GS-2 (Health, Governance) GS-3 (Science & Technology) GS-1 (Society) What Is Sickle Cell Disease (SCD)? Basics of CRISPR-Cas9 Gene Editing What is CRISPR-Cas9? Indian Improvement What Is Birsa-101 Gene Therapy? Mechanism How it differs from Casgevy (US therapy) Feature Birsa-101 (India) Casgevy (US/UK) Strategy Corrects the original mutation Increases […]

Why Hepatitis A deserves a place in India’s universal immunisation programme

 Why in news? Relevance Basics: what is Hepatitis A? Changing epidemiology Hepatitis A vs Typhoid: key contrasts Disease burden Treatment Vaccine characteristics Programmatic simplicity Cost-effectiveness Why Hepatitis A deserves priority Recommended strategy for India Public health rationale Overview Epidemiological relevance Programmatic feasibility Economic considerations Policy gap